How to Track Upcoming Initial Public Offerings (IPOs)
An IPO—or initial public offering—takes place when a company issues shares to the public for trading for the first time. IPOs are a way for new companies to raise equity capital from investors, and are often considered an exit strategy for early investors who can sell their shares at a premium.
Zenas BioPharma Announces Pricing of Upsized Initial Public Offering
Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies,
Know the risks in Initial public offering flipping
As a retail investor, your ability to hold on to your investment hurts. If you do not buy and hold equity assets for a long time, you cannot benefit from the gr
Galaxy Payroll Group Limited Announces Closing of $7 Million Initial Public Offering
Galaxy Payroll Group Limited (the "Company" or "GLXG"), a reputable payroll outsourcing service, employment service and consultancy and market research service
Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering
The gross proceeds to Bicara Therapeutics from the initial public offering, before deducting underwriting discounts and commissions and other offering expenses payable by Bicara Therapeutics, are expected to be approximately $315.00 million, excluding any exercise of the underwriters’ option to purchase additional shares of common stock.
MBX Biosciences prices $160M IPO at $16 per share
Clinical-stage biopharmaceutical company MBX Biosciences (NASDAQ:MBX) priced its initial public offering of 10.2M shares at $16.00 per share. The gross proceeds are expected to be $163.2M. Underwriters have a 30-day option to buy an additional 1.
MBX Biosciences Announces Pricing of Initial Public Offering
CARMEL, Ind., Sept. 12, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MBX) (“MBX Biosciences”), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders,
MBX Biosciences shares surge 44% in blockbuster Nasdaq debut
Shares of MBX Biosciences , which is developing therapies that target endocrine and metabolic disorders, including diabetes and obesity, jumped nearly 44% in their Nasdaq debut on Friday.
Upcoming IPOs: Seven public issues, 13 listings scheduled for next week; check full list here
The buzz in in the primary market is set to persist, with seven new public issues and thirteen listings planned for next week ...
The Envirotech Systems IPO Day 1: SME Public Issue Subscribed 2.5 Times; Retail Investors Lead Booking With 4.19x
The Envirotech Systems initial public offering (IPO) was fully subscribed within hours of its launch, demonstrating the high ...
Oman state-run oil firm will make initial public offering, potentially seek billions
An Omani state-run oil and gas company says it will make an initial public offering of its exploration and production ...
Osel Devices Limited Announces Initial Public Offering (IPO) on NSE EMERGE Platform
Osel Devices Limited (the "Company" or the "Issuer"), is in to the innovative technology sector, is proud to announce its ...
Nasdaq3d
Trident Digital Tech Holdings Announces Closing of Initial Public Offering
today announced that its previously announced initial public offering (the “Offering”) of 1,800,000 American Depositary Shares (“ADSs”) at a price to the public of US$5.00 per ADS closed ...
Oman state-run oil firm OQ will make initial public offering and potentially seek billions
An Omani state-run oil and gas company says it will make an initial public offering of its exploration and production ...
U.S. News & World Report6d
Oman State-Run Oil Firm OQ Will Make Initial Public Offering and Potentially Seek Billions
Oman State-Run Oil Firm OQ Will Make Initial Public Offering and Potentially Seek Billions DUBAI, United Arab Emirates (AP) — An Omani state-run oil and gas company announced Monday it will make ...